中文名:柳氮磺胺吡啶
英文名:Sulfasalazine (NSC 667219)
英文別名:Azulfidine, Salazopyrin, Sulphasalazine;2-?hydroxy-?5-?[2-?[4-?[(2-?pyridinylamino)?sulfonyl]?phenyl]?diazenyl]?-benzoic acid
純度:10mM in DMSO
貨號(hào):S409257
包裝:1ml
Cas號(hào):599-79-1
存儲(chǔ)溫度:-80℃儲(chǔ)存
產(chǎn)品介紹:
Information
Sulfasalazine (NSC 667219, Azulfidine, Salazopyrin, Sulphasalazine) is a sulfa derivative of mesalazine, used as an anti-inflammatory agent to treat bowel disease and rheumatoid arthritis. Sulfasalazine is a potent and specific inhibitor ofnuclear factor
In?vitro
Sulfasalazine, like methotrexate, enhances adenosine release at an inflamed site and that adenosine diminishes inflammation via occupancy of A2 receptors on inflammatory cells. Sulfasalazine treatment for 4 hours inhibits kappaB-dependent transcription with an IC50 value of approximately 0.625 mM. Sulfasalazine (2.5 mM) results in cell death of T-lymphocytes in a dose- and time-dependent manner. Sulfasalazine but not 5ASA or sulfapyridine, strongly inhibits NF-kappaB activation and potently induces apoptosis in T-lymphocytes. Sulfasalazine is cleaved into sulfapyridine and 5-aminosalicylic acid (5-ASA; mesalamine) by colonic bacteria, and the latter, too, is reported to suppress NF-kappaB activity. Sulfasalazine but not its cleaved form 5-ASA causes a dose-dependent inhibition of glioma growth, this effect is entirely attributable to the inhibition of cystine uptake via the system x(c)(-) cystine-glutamate transporter. Sulfasalazine inhibits cystine uptake causing a chronic depletion of intracellular GSH and consequently compromised cellular redox defense which stymied tumor growth.
In?vivo
Sulfasalazine markedly decreases the number of leukocytes that accumulated in the inflamed (carrageenan, 2 mg/ml) air pouch in the murine air pouch model of inflammation. Sulfasalazine treatment promotes a marked increase in splenocyte 5-aminoimidazole-4-carboxamidoribonucleotide (AICAR) concentration, which is consistent with the in vitro observation that sulfasalazine inhibits AICAR transformylase.
Cell?Data
cell?lines:p110β-reliant PTEN-deficient PC3 prostate and BT549 and HCC70 breast cancer cell lines.
Concentrations:Concentrations:
Incubation?Time:Incubation Time:
Powder?Purity:≥98%
查看阿拉丁官網(wǎng)此產(chǎn)品相關(guān)對(duì)應(yīng)頁(yè)面:https://www.aladdin-e.com/zh_cn/S409257.html
關(guān)鍵字: Azulfidine, Salazopyrin, Sulphasalazine;2-?hydroxy-?5-?[2-?[4-?[(2-?pyridinylamino)?sulfonyl]?phenyl]?diazenyl]?-benzoic acid
上海阿拉丁生化科技股份有限公司是A股上市公司((股票代碼:688179),專(zhuān)注于科研試劑的研發(fā)、生產(chǎn)和銷(xiāo)售,已陸續(xù)建立多個(gè)工廠和研發(fā)中心。作為領(lǐng)軍企業(yè),阿拉丁始終堅(jiān)持質(zhì)量第一,連續(xù)13年被評(píng)為“最受歡迎試劑品牌”。
阿拉丁目前常備庫(kù)存試劑產(chǎn)品品種超過(guò)7萬(wàn)種,SKU總數(shù)超過(guò)46萬(wàn),產(chǎn)品線涵蓋了化學(xué)試劑、生化試劑、藥靶配體、蛋白質(zhì)和抗體等多個(gè)領(lǐng)域,是國(guó)內(nèi)少數(shù)化學(xué)試劑到生物試劑全面發(fā)展的國(guó)產(chǎn)試劑品牌,產(chǎn)品同步發(fā)布在我們國(guó)內(nèi)外電商平臺(tái)。